Ikarian Capital’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,016	Closed	-$13.7K	–	177
2024 Q4	$13.7K	Buy	+6,016	New	+$11.1K	﹤0.01%	165
2024 Q3	–	Sell	-6,016	Closed	-$30.5K	–	164
2024 Q2	$30.5K	Hold	6,016	–	–	0.01%	112
2024 Q1	$51K	Hold	6,016	–	–	0.01%	131
2023 Q4	$24.6K	Hold	6,016	–	–	0.01%	131
2023 Q3	$18.1K	Sell	6,016 -6,646	-52%	-$151K	0.01%	136
2023 Q2	$391K	Hold	12,662	–	–	0.14%	102
2023 Q1	$627K	Hold	12,662	–	–	0.26%	90
2022 Q4	$311K	Hold	12,662	–	–	0.13%	68
2022 Q3	$839K	Sell	12,662 -4,233	-25%	-$212K	0.42%	73
2022 Q2	$698K	Sell	16,895 -3,382	-17%	-$152K	0.29%	92
2022 Q1	$1.02M	Buy	20,277 +974	+5%	+$47.8K	0.31%	100
2021 Q4	$1.16M	Hold	19,303	–	–	0.33%	95
2021 Q3	$955K	Sell	19,303 -244	-1%	-$12.8K	0.22%	158
2021 Q2	$1.11M	Hold	19,547	–	–	0.2%	155
2021 Q1	$1.12M	Buy	+19,547	New	+$1.48M	0.17%	235
2020 Q4	–	Hold	0	–	–	–	247
2020 Q3	–	Hold	0	–	–	–	189